Topic Highlight
Copyright ©2007 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 14, 2007; 13(42): 5577-5580
Published online Nov 14, 2007. doi: 10.3748/wjg.v13.i42.5577
Innate immunity in inflammatory bowel disease
Jesus K Yamamoto-Furusho, Daniel K Podolsky
Jesus K Yamamoto-Furusho, Daniel K Podolsky, Gastroin- testinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, United States
Author contributions: All authors contributed equally to the work.
Correspondence to: Jesus K Yamamoto-Furusho, MD, PhD, Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114, United States. kazuofurusho@hotmail.com
Telephone: +1-617-7267411 Fax: +1-617-7242136
Received: April 4, 2007
Revised: May 25, 2007
Accepted: August 1, 2007
Published online: November 14, 2007
Abstract

The human intestinal tract is home to an enormous bacterial flora. The host defense against microorganisms can be divided into innate and adaptive immunity. The former is the most immediate line of response to immunologic challenges presented by bacteria, viruses, and fungi. The mucosal immune system has evolved to balance the need to respond to pathogens while co-existing with commensal bacteria and food antigens. In inflammatory bowel disease (IBD), this hyporesponsiveness or tolerance breaks down and inflammation supervenes driven by the intestinal microbial flora. Bacteria contain compounds and are recognized by a variety of receptors, including Toll-like receptors (TLRs) and NODs (a family of intracellular bacterial sensors) and are potent stimuli of innate immune responses. Several mutations in these receptors have been associated with development of IBD.

Keywords: Innate, Immunity, Toll-like receptors, Inflammatory bowel disease